Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. Dr. Myers is currently CEO of FendX Technologies Inc. She is also a Principal of BioEnsemble LLC, where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. Dr. Myers is also a director at Mayne Pharma Group Ltd. and Hyloris Pharmaceuticals SA, both publicly listed companies. She is a member of Mid Atlantic Bio Angels and Golden Seeds. She earned her PhD in genetics from the University of British Columbia and her MBA from Rutgers University.